Yervoy (ipilimumab) - BMS
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
prednisone - Generic mfg.
methylprednisolone sodium succinate - Generic mfg.
Case Report: Neuroretinitis following combination checkpoint inhibition therapy with nivolumab and ipilimumab for stage IIIC melanoma. (PubMed, Front Oncol) - Sep 19, 2026 - "The patient was treated with intravenous methylprednisolone (IVMP) pulse and intravenous immunoglobulin (IVIG) at initial hospitalization, followed by a slow oral prednisone taper along with monthly IVIG outpatient. Prompt recognition, exclusion of infectious mimics, and multidisciplinary management can yield meaningful visual recovery. Comprehensive neuro-ophthalmic assessment for ICI-associated neuro-ophthalmic complications including evaluation of color vision and pupillary function, documentation of fundus appearance, and additional ancillary testing with visual field and OCT analysis is essential." 
Checkpoint inhibition • Journal • Cutaneous Melanoma • Genetic Disorders • Hematological Disorders • Macular Edema • Melanoma • Ocular Infections • Ocular Inflammation • Oncology • Ophthalmology • Retinal Disorders • Solid Tumor
http://www.ncbi.nlm.nih.gov/pubmed/42756432
 
Aaron B Roller; Jared Moon; Moe H Aung; Nuha S Arefin
 
Sep 19, 2026
 
Prev Next